Ohio Public Employees Retirement System (OPERS)
CTMX icon

Ohio Public Employees Retirement System (OPERS)’s CytomX Therapeutics CTMX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-82,028
Closed -$119K – 1973
2022
Q3 		$119K Buy
+82,028
New +$126K ﹤0.01% 1593
2022
Q1 		– Sell
-32,609
Closed -$141K – 2018
2021
Q4 		$141K Sell
32,609
-2,000
-6% -$11.7K ﹤0.01% 1611
2021
Q3 		$176K Hold
34,609
– – ﹤0.01% 1547
2021
Q2 		$219K Buy
+34,609
New +$269K ﹤0.01% 1492

Other funds holding CTMX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s CTMX Position: Q4 2022 in Review

Ohio Public Employees Retirement System (OPERS) sold out of CytomX Therapeutics (CTMX) in Q4 2022, closing a stake of 82,028 shares — an estimated $119K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in CTMX in Q2 2021 and held it in 4 quarters. The position peaked at $219K in Q2 2021. 81 funds tracked by Wall St. Rank hold CTMX as of Q4 2022.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining CytomX Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 82,028 CytomX Therapeutics shares in Q4 2022, an estimated $119K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in CytomX Therapeutics in Q2 2021 and held it in 4 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s CytomX Therapeutics position peaked at $219K in Q2 2021.
  • 81 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q4 2022.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2022, filed 15 Feb 2023.